Details

GcMAF eradicates autism in 15% of children; 85% improve, 15% do not respond. 59 research papers by 142 scientists state GcMAF rebuilds the immune system. Research by Dr Bradstreet shows that 85% of autistic children have high nagalase levels and therefore a compromised immune system. Introducing GcMAF causes the immune system to fight viruses, infections and fungal attacks.

With an improvement rate of 85%, this indicates that many of the problems experienced by autistic children are caused by a collapsed immune system, and a viral/bacterial/fungal overload. 1,500 autistic children have now been treated with Immuno Biotech Ltd’s GcMAF (gcmaf.eu), 15% of whom have made full recoveries from autism.